INTRODUCTION
The rational use of drugs (RDU) by physicians is mainly promoted through continuing medical education (CME) updates which are planned to enhance knowledge, skills and changes in attitude to prescribing. Prescribing is considered to be sacrosanct by physicians, and it is often very difficult to evaluate the effect of any intervention on prescribing. Attempts to achieve this can be by way of In countries where prescribing habits may not be ideal, it is possible to introduce programmes for the critical analysis of prescriptions for a group of physicians, rather than for an individual. There have been some attempts to examine prescribing patterns from India, mostly in an academic setting'.'.
A distance education programme for physicians from mission hospitals has been available since 1985 and this has been updated since 1990 with periodic news bulletins sent to all mission hospitals.
This study was done as part of a rational drug use programme organized by the Christian Medical Association of India (CMAI) in collaboration with the Christian Medical College Hospita13.'This project was started in July 1991 and is an ongoing programme. The first phase of the study, from July 1991 to January 1993, is reported here. Representatives from 60 mission hospitals participated in these workshops.
AIMS AND OBJECTIVES
The workshops were conducted with a variety of aims and objectives: to create an awareness among physicians in mission hospitals about RDU, especially antibiotics; provide an update on the selection and use of new drugs in the management of commonly encountered ambulatory care medical problems; examine prescribing from a limited drug list using a formulary; highlight drug-related reactions and interactions; and the need to report them with a view for monitoring drug safety. Further objectives were to evaluate critically medical literature, and to improve the day-to-day practice of pharmacy management, applying the principle of rational drug selection and cost effectiveness in their procurement. It was also felt to be important for the doctors themselves to educate the public about RDU and to encourage physicians to have similar discussions within their organizations to enable periodic assessment and follow-up patterns. study of drug use Table 3 
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METHODS
At least 2 months in advance invitations were sent out in the selected regions to all mission hospitals, highlighting the objectives of the workshop and requesting their participation. The workshops were conducted at various centres each serving as a focal point for their particular region. They were usually held at weekends and lasted 2 daysa total of 14 to 16 h in all.
The format of the workshops comprised group and panel discussions, problem solving exercises on patient management, critical evaluation of newly introduced drugs, an open forum for question and answer and video demonstrations. Participant interaction was encouraged by having small group disctmions.
On the morning of the workshop, a questionnaire (multiple choice questionnaire) was given to the participants. The questionnaire was designed to highlight: the average number of drugs in the participants' prescriptions; the cost of drugs per prescription; the availability of an antibiotic policy; and guidelines for clinical management in the hospital. There were questions on the role of the pharmacy therapeutic committee in guiding the selection of; drugs; drug dispensing and procuring practices; the presence or absence of a formulary; the inclusion of drugs in the formulary; the number of injections per prescription; the number of unnecessary drugs stocked; and an awareness of adverse drug reactions; etc. Sixty participants of whom 14 were medical superintendents from 60 different hospitals, answered the pre-workshop questionnaire. The same questionnaire was administered to the same participants 6 months after the workshop and 51 answered the post-workshop questionnaire. The information received was assessed, based on some of the 'indicators for RDU' tested e l s e~h e r e~.~ to evaluate the impact of our intervention.
RESULTS
A total of 60 physicians representing 60 hospitals participated. Among them: six were postgraduates; thirty were less than 40 years old; and 40 had been in practice for at least 15 years since graduation.
The bed strength of the hospitals was between 50 and 300. Twenty-three hospitals had a bed strength of up to 100, 24 hospitals up to 200 and 13 had over 200. The number of out-patients on working days averaged up to: I50 per day in 38 hospitals; 300 in 15 hospitals; and over 300 in seven hospitals. Table 1 shows the patients' drugs sources. The number of prescriptions filled from the hospital's pharmacy has increased, in comparison to a drop in the number of those serviced by drug stores following the workshop. Tables 2 and 3 give the average number of drugs per prescription before and after the workshops. The number of prescriptions containing only two drugs has increased (P< 0.05). The number of prescriptions with three or more drugs has decreased but this is not significant statistically. Overall, there is a trend towards prescribing fewer drugs per prescription but this is not statistically significant. Table 4 gives information on the cost of drugs. Cost was clearly indicated in all post-workshop questionnaire responses, whereas in the pre-workshop questionnaire more than 20% of respondents had given no information about cost. The increase in the number of prescriptions costing over Rs 40/-(US$I =Rs 36/-), which is not statistically significant, is likely to be due to a general increase in drug prices as there was no significant increase in the number of drugs prescribed (mean number of drugs 3.16 versus 3.04). The prices were based on the calculated prices on the prescriptions as estimated by the participant. Table 5 gives a list of indicators that were checked before and after the interventions. Statistically, no significant differences were observed between the preand post-workshop questionnaires for many of the indicators. However, 34% of respondents had deleted a . The number of injections used as an indicator gives information on drugs used for immunizations and. rheumatic fever prophylaxis mainly. The number of multivitamins and antipyretic injections has decreased but was not quantified in all the responses.
A scoring system was suggested for the addition of any new drug in the formulary6: 49.1% had added new drugs in their pharmaciesmainly quinolones, cephalosporins, angiotensin-converting enzyme (ACE) inhibitors and newer H-2 blockers.
The effect of the workshop on 'formulary usage' is shown in Table 6 . The number of hospitals with 'no formulary' had not changed significantly, but the number using CMAI formulary has significantly increased (P<O.OOl).
The pattern of drug purchases in the pharmacy before and after workshops are shown in Table 7 .
The selection of drugs based on turnover and drug stocking for a reasonable period of 1 month has significantly increased ( P < 0.05). The percentage of 'emergency' purchases ( P < 0.01) and drugs received through donations from overseas ( P < 0.01) have come down significantly.
The regulation of the visits by drug representatives as indicated in Table 8 show that the interaction of representatives with all doctors has significantly increased (P<O.O5).
DISCUSSION
The study was conducted to examine the role of an educational intervention in improving drug use skills as measured by some of the indicators of RDU. Since the study covered hospitals where the physicians had a key role in drug purchasing and prescribing, aspects of prescribing as well as pharmacy purchases were also looked at. The methodology used was an analysis of responses to the questionnaire sent to the participants 6 months before and after the workshop. The limitation of this approach is that it only measures the changes perceived by the participants and it does not represent the observations of the authors in regard to changes in practice.
The number of prescriptions dispensed from hospitals' own pharmacies increased and the number from drug stores decreased. It is possible that due to fluctuating availability, many drugs can be 'out of stock' and when they are not available in the hospital pharmacy patients are then directed to obtain drugs from elsewhere. The hospital's pharmacy purchase committee should respond quickly to market situations so that quality drugs can be dispensed from the hospital pharmacies.
The average number of drugs per prescription is considered as an indicator of RDU. In this group the mean (SEM) was found to be 3.16 (0.85) before the workshop and had not changed significantly after the workshop. The average number of drugs per prescription as reported from 10 developing countries varied between 1.3-3.S5. Indonesia and Sudan had rates of 3.3 and 3.8, respectively, which are comparable to the present study figures 3.16 (0.95) after the workshop.
Overall, there appears to be a decline in the number of prescriptions with a higher number of drugs, but the difference between pre-and post-workshop figures is not significant.
'Cost of drugs' was answered by a larger number of physicians after the workshop. This may be due to increased awareness about costs of drugs after the workshop. Studies have shown that one of the reasons for failure of therapy is poor compliance with drugs due to the price and it is important that physicians be aware of this when prescribing'.*. In countries like India, cost is a major limitation. It is common to see patients buying only one or two doses of a drug because they are unable to afford the full course. Therefore, it is very important that the physician knows about actual treatment costs in order to help select appropriate cost-effective treatment.
The selected indicators of drug use4x5 have been tried out in various countries. Though no statistically significant differences were seen, it was felt that there was an increasing awareness of many indicators e.g. the number of drugs per prescription, the role of a pharmacy therapeutic committee in making more rational and acceptable decisions. The number of injections has not decreased significantly as immunization programmes, quite properly, continued as before. It has not been possible to determine whether prescriptions for unnecessary injections of vitamins, antibiotics and other drugs have changed. There is no significant improvement in the elimination of unwanted drugs such as tonics and cough suppressants. The number of indigenous products for liver and cardiovascular diseases increased, but this was not separately quantified in the responses. The increase could probably be due to media publicity which has been widely promoting herbal products.
The introduction of new drugs and the elimination of drugs of unproven value could be due to promotional activities, or peer pressures, or simply an update. Most of the newer drugs used were newer antibiotics, antihypertensives and H2 blockers. Not all respondents answered this section of the post-workshop questionnaire. The scoring system for the selection of essential drugs6 may be invaluable in helping the physician to make the right choices. Educational programmes by voluntary organizations such as these workshops and media propaganda may have a role in increasing awareness of newer drugs and their relative merits or demerits.
Similarly, the drug purchases based on the movement of drugs, cost, etc., could decrease overstocking and non-movement and prevent the situation 'out of stock'. The positive findings are a significant reduction of 'emergency purchases' (last minute purchases from wherever available) and increased stocking for longer periods based on turnover. The acceptance of drug donations from overseas has significantly decreased. The guidelines for accepting such donations circulated earlier through the CMAI may have had a significant role in this9.
The workshops emphasized the need to be aware of drug treatment costs and gave comparative treatment costs based on treatment guidelines developed by consensus at the teaching hospital. The sources of information on drug costs, such as MIMS (Monihly Index of Medical Specialities) and CIMS (Current Index of Medical Specialities), were brought to the attention of the participants.
Discussions also highlighted the relationship between drug costs and poor compliance leading to treatment failure. The need for hospital formularies to improve rational prescribing and to streamline cost has been stressed'O. The introduction of the CMAI Hospitals Formulary 4 years ago, its promoting and periodical updating3, have considerably increased the number of mission hospitals who prescribe from a formulary. The scoring system for the selection of drugs for stocking and prescribing was also introduced into the workshop6.
The role of medical representatives in influencing prescribing patterns has been noticed earlier and attempts to alter it by various methods such as academic detailing have been advised". During the workshop, sessions on critical evaluation of promotional material were an attempt on our part to alert practitioners to the role of medical advertising in changing prescription patterns, and to emphasize the need for caution when considering newly introduced drugs.
CONCLUSIONS
The impact of distance education followed by direct interaction through workshops has been useful in that it has created awareness of many aspects of RDU. The positive impacts of these workshops have been in: sensitizing the practitioners to rational drug use; prescribing from a formulary; decreasing money spent on stocking drugs of unproven value; the judicious selection of drugs; the concept of a pharmacy and therapeutic committee; an antibiotic policy; and critical evaluation of drug literature.
Not all of the aims and objectives have been achieved; one reason could be that the evaluation may have been too early. Moreover, we have not evaluated the cost effectiveness of such an intervention in terms of resources of time, people and material. In a vast country such as India, more direct teaching by university level teachers with an interest in this area would be effective and it is essential that both governmental and nongovernmental agencies work together to effect a wave of change. Tangible benefits include: cost savings in health care delivery; savings through avoidance of adverse drug reactions; and/or change in ecology through antibiotic misuse and drug resistance.
It is our firm belief that RDU workshops need to be repeated and re-emphasized periodically. Our past experience shows that 'improvement peaks' seen after workshops tend to diminish if not regularly reinforced. The Family AIDS Caring Trust (FACT) was formed in Mutare, Zimbabwe's third largest city, in 1987. FACT'S home care programme started in 1992. The programme operates in the urban area of Mutare' which contains three townships with a population of 131 367. The area employs a trained nurse as a coordinator and four assistants, each assigned a zone within the city, who carry out the bulk of the visits.
As part of an evaluation of the programme we attempted to estimate its coverage using different models. Using these models the FACT programme has a coverage of between 2.5%-23%. It is important that all home care programmes think in terms of coverage and do not simply strive to provide high quality services to a few patients. INTRODUCTION Community-based home care programmes have been introduced in a number of African countries since 1987
